Medicine and Dentistry
Infection
100%
Severe Acute Respiratory Syndrome Coronavirus 2
94%
COVID-19
62%
Hospital
56%
Patient
47%
Therapeutic Procedure
30%
Analysis
29%
Epidemic
27%
Genome Sequencing
26%
Infection Control
22%
Infection Prevention
18%
Clinical Feature
16%
Emergency Department
16%
Antigen
16%
Whole Genome Sequencing
16%
Disease
16%
Mortality
16%
Combination Therapy
14%
Ritonavir
13%
Assay
13%
Diagnosis
11%
Antibody Response
11%
Evaluation Study
11%
Child
11%
Man
11%
Woman
11%
Polymerase Chain Reaction
10%
Gene
9%
Antivirus Agent
9%
Association
9%
Health Care Cost
9%
Cohort Analysis
9%
Polymerase Chain Reaction
9%
Intensive Care
8%
Morbidity
8%
Antithrombotic
8%
Human Immunodeficiency Virus
8%
Disease Severity
8%
Superantigen
8%
Hepatitis C
8%
Hepatitis B
8%
Molecular Epidemiology
8%
Warfarin
8%
Streptococcus Group A
8%
Influenza
8%
National Health Service
8%
Hepatitis C Virus
8%
Nirmatrelvir
8%
Antiphospholipid Syndrome
8%
Public Health Planning
8%
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
39%
COVID-19
27%
Antigen
18%
Breakthrough Infection
16%
Neutralization
16%
Health
12%
Flow
12%
Antibody Response
11%
Neutralizing Antibody
10%
Gene
9%
Human Immunodeficiency Virus
9%
Sample
9%
Morbidity
9%
Spike
8%
Polymerase Chain Reaction
8%
Hepatitis C
8%
Streptococcus pyogenes
8%
Hepatitis C Virus
8%
Influenza
8%
Hepatitis B
8%
Mortality
8%
Superantigen
8%
Streptococcus Group A
8%
Molecular Epidemiology
8%
Development
8%
Amplicon
8%
Time
8%
Sampling
8%
Vaccine Efficacy
7%
Hospital Mortality
7%
Lineages
6%
Infectious Agent
5%
Polymerase Chain Reaction
5%
Blood Borne Virus
5%
Hepatitis B Virus
5%
